BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22967872)

  • 1. Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large B-cell lymphoma: a review of the literature.
    Tirado CA; Chen W; García R; Kohlman KA; Rao N
    J Hematol Oncol; 2012 Sep; 5():54. PubMed ID: 22967872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Array-comparative genomic hybridization profiling of immunohistochemical subgroups of diffuse large B-cell lymphoma shows distinct genomic alterations.
    Guo Y; Takeuchi I; Karnan S; Miyata T; Ohshima K; Seto M
    Cancer Sci; 2014 Apr; 105(4):481-9. PubMed ID: 24843885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of copy number gains and losses, detected by array-based comparative genomic hybridization, for computational differential diagnosis of B-cell lymphomas and genetic regions involved in lymphomagenesis.
    Takeuchi I; Tagawa H; Tsujikawa A; Nakagawa M; Katayama-Suguro M; Guo Y; Seto M
    Haematologica; 2009 Jan; 94(1):61-9. PubMed ID: 19029149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS).
    Carreras J; Kikuti YY; Beà S; Miyaoka M; Hiraiwa S; Ikoma H; Nagao R; Tomita S; Martin-Garcia D; Salaverria I; Sato A; Ichiki A; Roncador G; Garcia JF; Ando K; Campo E; Nakamura N
    Histopathology; 2017 Mar; 70(4):595-621. PubMed ID: 27775850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma.
    Chang CC; Zhou X; Taylor JJ; Huang WT; Ren X; Monzon F; Feng Y; Rao PH; Lu XY; Fabio F; Hilsenbeck S; Creighton CJ; Jaffe ES; Lau CC
    J Hematol Oncol; 2009 Nov; 2():47. PubMed ID: 19909553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and analysis of tree models for chromosomal classification of diffuse large B-cell lymphomas.
    Jiang HY; Huang ZX; Zhang XF; Desper R; Zhao T
    World J Gastroenterol; 2007 Mar; 13(11):1737-42. PubMed ID: 17461480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.
    Bea S; Zettl A; Wright G; Salaverria I; Jehn P; Moreno V; Burek C; Ott G; Puig X; Yang L; Lopez-Guillermo A; Chan WC; Greiner TC; Weisenburger DD; Armitage JO; Gascoyne RD; Connors JM; Grogan TM; Braziel R; Fisher RI; Smeland EB; Kvaloy S; Holte H; Delabie J; Simon R; Powell J; Wilson WH; Jaffe ES; Montserrat E; Muller-Hermelink HK; Staudt LM; Campo E; Rosenwald A;
    Blood; 2005 Nov; 106(9):3183-90. PubMed ID: 16046532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New chromosome abnormalities and lack of BCL-6 gene rearrangements in Argentinean diffuse large B-cell lymphomas.
    Cerretini R; Noriega MF; Narbaitz M; Slavutsky I
    Eur J Haematol; 2006 Apr; 76(4):284-93. PubMed ID: 16519699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].
    Luo DL; Liu YH; Zhuang HG; Li L; Xu FP; Zhang F; Luo XL; Xu J
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma.
    Li S; Young KH; Medeiros LJ
    Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual CGH: an integrative approach to predict genetic abnormalities from gene expression microarray data applied in lymphoma.
    Geng H; Iqbal J; Chan WC; Ali HH
    BMC Med Genomics; 2011 Apr; 4():32. PubMed ID: 21486456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma.
    Skacel M; Ross CW; Hsi ED
    Histopathology; 2000 Jul; 37(1):10-8. PubMed ID: 10931213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based review of genomic aberrations in diffuse large B cell lymphoma, not otherwise specified (DLBCL, NOS): Report from the cancer genomics consortium lymphoma working group.
    Yenamandra AK; Smith RB; Senaratne TN; Kang SL; Fink JM; Corboy G; Hodge CA; Lu X; Mathew S; Crocker S; Fang M
    Cancer Genet; 2022 Nov; 268-269():1-21. PubMed ID: 35970109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.
    Lenz G; Wright GW; Emre NC; Kohlhammer H; Dave SS; Davis RE; Carty S; Lam LT; Shaffer AL; Xiao W; Powell J; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Campo E; Jaffe ES; Delabie J; Smeland EB; Rimsza LM; Fisher RI; Weisenburger DD; Chan WC; Staudt LM
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13520-5. PubMed ID: 18765795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
    Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
    Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.
    Sebastián E; Alcoceba M; Martín-García D; Blanco Ó; Sanchez-Barba M; Balanzategui A; Marín L; Montes-Moreno S; González-Barca E; Pardal E; Jiménez C; García-Álvarez M; Clot G; Carracedo Á; Gutiérrez NC; Sarasquete ME; Chillón C; Corral R; Prieto-Conde MI; Caballero MD; Salaverria I; García-Sanz R; González M
    Ann Hematol; 2016 Jan; 95(2):253-62. PubMed ID: 26573278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities.
    De Paepe P; De Wolf-Peeters C
    Leukemia; 2007 Jan; 21(1):37-43. PubMed ID: 17039226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles.
    Dubois S; Tesson B; Mareschal S; Viailly PJ; Bohers E; Ruminy P; Etancelin P; Peyrouze P; Copie-Bergman C; Fabiani B; Petrella T; Jais JP; Haioun C; Salles G; Molina TJ; Leroy K; Tilly H; Jardin F;
    EBioMedicine; 2019 Oct; 48():58-69. PubMed ID: 31648986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution array comparative genomic hybridization identifies copy number alterations in diffuse large B-cell lymphoma that predict response to immuno-chemotherapy.
    Kreisel F; Kulkarni S; Kerns RT; Hassan A; Deshmukh H; Nagarajan R; Frater JL; Cashen A
    Cancer Genet; 2011 Mar; 204(3):129-37. PubMed ID: 21504712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.